Abstract
Introduction
Mesenchymal stem cells (MSCs) have been described as undifferentiated multipotent cells with the ability of both self-renewing and differentiation into a wide range of cells of mesenchymal lineages, such as osteoblasts, chondrocytes, adipocytes, (bone marrow) stromal cells, fibroblasts and tendons, but also of ectodermal and endodermal types (hepatocytes, neural cells, lung cells, and endothelial cells) [1, 2] . MSCs were originally isolated from bone marrow [3] but cells with generally similar, although not always identical properties were found in diverse adult tissues (peripheral blood, adipose tissue, trabecular bone, synovial membrane, dental pulp, etc.), as well as in birth-associated tissues (placenta, amnion, umbilical cord, and cord blood) [1, 2] .
For the last two decades MSCs have gained much attention because of their regenerative, reparative and angiogenic properties [1, 4] . Additional therapeutic potential of MSCs is related to their capacity to modulate the Immunomodulatory capacity of human mesenchymal stem cells isolated from adipose tissue, dental pulp, peripheral blood and umbilical cord Wharton's jelly immune response exerting effects on cells of both innate and adaptive immunity [2, 5, 6] . The immunomodulatory effects of MSCs include suppression of T cell proliferation, induction of regulatory T cells, suppression of B cell proliferation and their terminal differentiation, inhibition of NK cell function, as well as inhibition of differentiation and expression of stimulatory molecules on dendritic cells [2] . However, the mechanisms by which MSCs exert their immunomodulatory activity are only partly understood, although it is likely that mechanisms involving both soluble factors and cell-cell contacts are involved. There is growing evidence that key relevant mediators of MSC-mediated immunomodulation include but are not limited to: transforming growth factor-β (TGF-β), cyclooxygenase-1 (COX-1) and COX-2, which synthesizes prostaglandin E2 (PGE2), indoleamine 2,3 deoxygenase (IDO), nitric oxide (NO), human leukocyte antigen (HLA)-G5, interleukin 6 (IL-6), IL-10 [2, 6] . Another open issue is the relation of the MSCs immunomodulatory phenotype to the microenvironmental context, since recent data indicated that both MSCs behavior and function are influenced by cytokines and other factors secreted or accumulated in the microenvironment, especially within the inflamed tissue [7] [8] [9] .
MSCs of diverse origin are currently available, and each type has its own strength and shortcomings. Our group has recently isolated MSCs from four different human tissues: peripheral blood (PB), umbilical cord Wharton's jelly (UC), adipose tissue (AT), and dental pulp (DP) from deciduous teeth, [10, 11, our submitted manuscript], whose common feature is that all are discarded after routine medical interventions and therefore are a readily available source for MSCs isolation. It is well documented that MSCs phenotype, proliferative, clonogenic and differentiation potential, as well as the immunomodulatory properties are influenced by tissue origin, donor-related health condition and age, isolation technique, cultivation, propagation, and storage conditions [12] [13] [14] . Therefore, comparative evaluation of MSCs from different sources is needed to address the existence of possible differences. In this study, with an aim to determine how tissue origin and/or proinflammatory cytokines influence the immunomodulatory phenotype, we have compared MSCs obtained from peripheral blood, umbilical cord Wharton's jelly, adipose tissue and deciduous teeth-dental pulp by evaluating their in vitro immunomodulatory capacities, as well as the gene expression of several molecules that are of importance in determination of the nature of the response generated by MSCs.
Material and methods

MSCs isolation and culture
Cell samples were obtained in accordance with the ethical standards of the local ethical committee and the Declaration of Helsinki, and after providing informed consent of study subjects. MCSs from human dental pulp of deciduous teeth (DP-MSCs), peripheral blood (PB-MSCs), umbilical cord Wharton's jelly (UC-MSCs), as well as from adipose tissue (AT-MSCs), were isolated and their MSCs identity confirmed as previously described [10, 11] .
After isolation, AT-MSCs, PB-MSCs, and UC-MSCs were further cultivated in the growth medium (GM) consisting of Dulbecco's Modified Eagle's Medium (DMEM, Sigma-Aldrich) supplemented with 10% Fetal Bovine Serum (FBS) and Penicillin/Streptomycin (all from PAA, Linz, Austria), whereas DP-MSCs were cultured in GM with 200 μM ascorbic acid-2-phosphate (Sigma-Aldrich, St. Louis, MO, USA). Cells were seeded in 25 cm 2 plastic tissue culture flasks at a concentration of 1 × 10 4 cells/cm 2 and incubated in a humidified atmosphere at 37 o C and 5% CO 2 with the medium replaced every 2-3 days. After achieving 80-90% of confluence, MSCs were detached by 0.25% trypsin-EDTA solution (PAA) and replated at the same cell density. All experiments were performed using MSCs between passages 4 and 6.
PBMCs isolation
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats of healthy donors by density gradient centrifugation using Lymphoprep medium (PAA).
Conditioned media preparation
The conditioned medium (CM) derived from MSCs was obtained as described previously [15] . In brief, after reaching 80% of confluence, the cell culture medium was replaced by fresh GM. After additional 48 h of cultivation, CM-MSCs were collected. The CM-MSCs, containing factors constitutively secreted by unstimulated MSCs, were centrifuged for 10 min at 500 ×g and aliquots stored at -70 o C until use.
In vitro assays for testing MSCs modulatory effects on PBMCs proliferation
One-way mixed lymphocyte reaction (MLR)
To determine if MSCs function as alloantigens presenting cells one-way MLR was applied. MSCs at concentrations of 1 × 10 4 or 1 × 10 3 were plated in 96-well plates in GM and allowed to adhere at 37°C in 5% CO 2 . After overnight incubation, MSCs were treated with Mitomycin C (25 μg/ml) (Applichem, Darmstadt, Germany) for 30 min at 37°C. After washing MSCs with phosphate buffered saline (PBS, PAA, Linz), GM (200 ml/well) was added along with freshly isolated responder PBMCs (1 × 10 5 cells). Cultures of PBMCs seeded alone were used as controls. On day 2, cultures were pulsed with 1 × 10 -5 M BrdU (Sigma-Aldrich) for the final 24 h. The level of proliferation, i.e. the level of BrdU incorporation, was measured using a modified method [16] . In brief, ethanol/HCl fixed cells were incubated 
Mitogen-stimulated PBMCs proliferation
To estimate the effects of MSCs on phytohaemagglutinin (PHA)-stimulated proliferative response of allogeneic PBMCs, freshly isolated responder PBMCs (1 × 10 5 /well), stimulated with 2.5 μg/ml PHA (INEP, Zemun, Serbia) were added in GM to MSCs cultures, previously seeded and treated with Mitomycin C, as described above. Cultures of unstimulated and PHA-stimulated PBMCs seeded without MSCs were used as controls. On day 2, cultures were pulsed with 1 × 10 -5 M BrdU for the final 24 h of culture. The level of proliferation was measured as described above. All experiments were performed in triplicate.
Two-way MLR
To assess the effects of MSCs on two-way MLR (as a third part in MLR), PBMCs of unrelated donors (1 × 10 5 cells of each) were co-cultured in GM with MSCs previously seeded and treated with Mitomycin C as described above. Co-cultures of responder PBMCs and allogeneic stimulator PBMCs without MSCs were used as controls. On day 5, cultures were pulsed with 1 × 10 -5 M BrdU for the final 24 h. The level of proliferation was measured as described above. All experiments were performed in triplicate.
Conditioned media experiments
The effects of MSCs-derived soluble products were assessed in both PHA-stimulated PBMC proliferation and the one-and two-way MLR. Briefly, 1 × 10 5 responder PBMCs, incubated in the presence or absence of 2.5 μg/ml PHA, or with 1 × 10 5 PBMCs of unrelated donors for the MLR, were exposed to GM supplemented with 20% CM of each MSCs type for 3 or 6 days and cultured in triplicate at 37°C, 5% of CO 2 before the MTT assay was carried out. The experiments were performed at least three times and cultures without CM were used as controls. The PBMC proliferation rate was determined by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Three hours after adding 0.5 mg/ml MTT (Sigma-Aldrich), the formazan crystals were dissolved in 10% SDS with 0.01 N HCl and absorbance read at 540 nm.
Reverse transcription-polymerase chain reaction (RT-PCR)
For gene expression analyses, MSCs treated or not with recombinant human IFN-γ (50 ng/ml) and/or TNF-α (20 ng/ml) (all from R&D Systems, Minneapolis, MN, USA) for 7 days were used. In a separate experiment, subconfluent MSCs were co-cultured for 2 days, with 1 × 10 6 allogeneic unstimulated or PHA-stimulated PBMCs. Cells grown only in GM were used as controls. Total RNA from MSCs was extracted using TRIzol (Invitrogen, Carlsbad, California, USA) and complementary DNA generated by the RevertAid TM Hminus First Strand cDNA Synthesis Kit (Fermentas, Life Science, Glen Burnie, MD, USA) using oligo (dT) as a primer. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a control for the amount of cDNA present in each sample. The primers sets were all purchased from Invitrogen, Carlsbad, CA (Table  1) . PCR bands were quantified by densitometry using the ImageMaster TotalLab v1.11 software (Amersham Pharmacia Biotech, Uppsala, Sweden). The expression level of each gene was normalized to GAPDH and set as 1 for control culture. The relative expression in stimulated MSCs was expressed as "fold change" compared to the control. 
Statistical analyses
The results are presented as the mean ± standard deviation (SD). The statistical significance of differences between two groups was determined by the two-tailed Student's t-test. Differences with P-values of < 0.05 were considered significant. Next, we evaluated the effect of MSCs on the mitogen-mediated lymphocyte proliferation and obtained results demonstrated that all tested MSCs inhibited the proliferation of PBMCs in response to PHA treatment in a MSC concentration-dependent manner (Fig. 1B) . The UC-MSCs significantly inhibited the PBMC proliferation at both cell concentrations tested, i.e. at MSCs/PBMCs ratio of 1 : 10 and 1 : 100, whereas AT-MSCs, DP-MSCs, Further on, we investigated the influence of different MSCs on MLR triggered by allogeneic antigens and results shown in Fig. 1C confirmed that all MSC populations suppressed the proliferation of PBMCs induced by allogeneic PBMCs, with AT-MSCs exhibiting the most significant inhibitory effect. Although all cell populations inhibited the MLR in a MSC concentration-dependent manner, the effects varied regarding the cell concentration, i.e. the MSC/ effector cell ratio, at which higher levels of suppression were observed. Namely, for the AT-MSCs and UC-MSCs, significant inhibition was detected with both MSC concentrations used, for DP-MSCs a more prominent effect was seen at the 1 : 100 MSC/effector cell ratio, whereas PB-MSCs exhibited significant effect when there was a 1 : 10 MSC/effector cell ratio.
Results
Immunomodulatory properties of different MSC populations
To assess the effects of MSC-secreted bioactive molecules, we next investigated the capacity of their conditioned medium (CM) to affect either the spontaneous or mitogen-induced proliferation of allogeneic PBMCs, as well as the MLR reaction. As shown in Fig. 2 , CM derived from DP-MSCs, PB-MSCs and UC-MSCs, considerably suppressed the proliferation of allogeneic PBMC ( Fig. 2A) , the PHA-mediated proliferation (Fig. 2B ) and the MLR (Fig. 2C) . On the other hand, although the MLR was effectively inhibited (Fig. 2C) , the AT-MSCs-derived CM failed to suppress the baseline proliferation capacity of the PBMCs (Fig. 2A) , as well as their PHA-induced responses (Fig. 2B ), most probably due to marked individual variations within the effects detected for different PBMCs donors.
Analysis of immunomodulatory related genes expression in different MSC populations
The expression of genes related to MSCs immunomodulatory functions was next investigated and compared. Beside their constitutive expression profiles in the MSC populations studied, transcript levels of HLA-A, HLA-G, HLA-DR, IL-6, TGF-β, COX2 and IDO-1 were also analyzed following the IFN-γ and TNF-α stimulation, since the proinflammatory microenvironment, including these two cytokines, has been implicated in the initiation of the MSCs immunomodulatory phenotype (Fig. 3) .
Regarding the members of the HLA family, the constitutive expression of both classical HLA-A class I and non-classical HLA-G5 class I molecules, as well as the HLA-DR, was not detected in PB-MSCs, UC-MSCs and DP-MSCs, while low levels of HLA-A and HLA-DR mRNA were detected only for AT-MSCs. As for the basal gene expression of the molecules related to the paracrine effects of MSCs, a low level of IDO-1 transcript was determined only in AT-MSCs, whereas AT-MSCs, PB-MSCs and UC-MSCs displayed similar low expression levels for the TGF-β mRNA. Concerning the IL-6 and COX2 marked expression of their transcript levels was demonstrated for the AT-MSCS and DP-MSCs.
Further on, the gene expression in MSCs was determined after cytokine treatment and as shown in Fig. 3 , the effects of the two proinflammatory cytokines used, differed between the MSC populations. In AT-MSCs, in response to IFN-γ and TNF-α, either alone or combined, an augmented expression of almost all tested genes (HLA-A, HLA-DR, HLA-G, COX2, IDO-1, IL-6 and TGF-β) was determined. It is worth mentioning that IFN-γ and TNF-α 
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combined stimulation did not induce synergistic upregulation of the tested genes. As for the DP-MSCs, the opposite effect was observed, since only the combined cytokine pre-treatment increased the expression of HLA-A, HLA-G5, COX2 and IL-6. Regarding the PB-MSCs, pre-treatment with these two proinflammatory cytokines did not alter the mRNA expression of tested molecules, while in response to IFN-γ and TNF-α, a slightly stimulated expression of HLA-G molecule and TGF-β was determined in UC-MSCs.
Discussion
In our laboratory MSCs from adipose tissue, dental pulp of deciduous teeth, peripheral blood and Wharton's jelly of umbilical cord were recently isolated and characterized exhibiting typical MSC morphology, clonogenic potential, immunophenotype and multipotent capacity to differentiate along mesenchymal lineages (osteogenic, chondrogenic, adipogenic and myogenic) in vitro [10, 11] . It is known that MSCs isolated from different tissues have similar but not identical capacity to modulate immune response. There are studies in which immunomodulatory properties of MSCs isolated from different tissues were directly compared [17] [18] [19] [20] , but because of a great variety in applied experimental procedures it is still difficult to know which of these MSCs are the most suitable for a specific therapeutic approach. Our results showed that types of MSCs analyzed in this study differed in both, capacity to modulate proliferation of allogeneic PBMCs and, constitutive or induced (by proinflammatory cytokines) expression of several genes related to the immunomodulatory properties of MSCs.
We showed, as expected, that in the direct cell culture all MSCs types inhibited the proliferation of PBMCs in response to both the mitogen (PHA) and alloantigens. We performed our assays at relatively high MSCs to PBMCs ratios of 1 : 10 and 1 : 100, which according to previous data are "more physiological" than lower MSCs to responder cell ratio [21] . The inhibition of PBMCs proliferation obtained was cell-concentration dependent. Namely, for PHA-stimulated PBMCs proliferation, all MSCs types induced a more pronounced inhibitory effect at lower 1 : 10 MSCs to PBMCs ratio. Besides, for alloantigen-induced PBMCs proliferation more prominent inhibition was induced by AT-MSCs and UC-MSCs at both cell concentrations used, whereas DP-MSCs and PB-MSCs exerted an inhibitory effect only at 1 : 100 or 1 : 10 MSCs/PBMCs ratios, respectively. Data that cell ratio determines whether MSCs would act as stimulators or inhibitors have been published previously [9, 22] .
Regarding the allostimulatory function, DP-MSCs, PB-MCSs, and UC-MSCs did not provoke alloreactivity in vitro, but in contrast to them, AT-MSCs stimulated proliferation of allogeneic PBMCs, but only at the 1 : 10 AT-MSCs to PBMCs ratio. Other authors have also demonstrated that MSCs are able to provoke alloimmune response both in vitro [23] and in vivo [24] . Furthermore, the allostimulatory function previously demonstrated for bone marrow MSCs was shown to be dependent on cell-tocell contact, but not on the soluble factor(s), as it was not abolished when metabolic activity of MSCs was prevented by pretreatment with cross-linking fixatives [23] . In addition, the allostimulatory function of MSCs demonstrated in that study was related to the constitutive membrane expression of HLA-DR molecule. However, the AT-MSCs used in our study constitutively express HLA-DR mRNA but not the membrane HLA-DR protein (our submitted manuscript), being in accordance with reports that HLA-DR molecules are habitually not expressed as surface markers unless MSCs are stimulated/primed within the inflammatory milieu [25, 26] . Nevertheless, to better understand the mode of action of AT-MSCs on PBMCs proliferation, further studies should be performed to determine if increased AT-MSCs-stimulated proliferation of PBMCs was the result of stimulated proliferation of regulatory T cells as previously shown [27] .
Immunomodulatory activity of MSCs could be mediated by direct cell contact or by secreted molecules [18, 28, 29] and which mechanisms predominate is highly dependent on the applied experimental design. There are several articles demonstrating opposite effects of constitutively secreted molecules by MSCs on proliferation of allogeneic lymphocytes [2, 15, 17] . Our results showed that CM of confluent, unstimulated MSCs also differentially modulate proliferation of PBMCs. Namely, CM derived from DP-MSCs, PB-MSCs, and UC-MSCs considerably suppressed the proliferation of allogeneic PBMC, as well as the proliferation of PBMCs in response to the mitogen and alloantigens. On the other hand, AT-MSCs' culture supernatant exerted different immunomodulatory properties, as it effectively inhibited MLR, but had no effect on baseline proliferation capacity and PHA-stimulated proliferation of PBMCs. The observed inhibitory effect of CM derived from DP-MSCs, PB-MSCs, and UC-MSCs on proliferation of PBMCs could be a consequence of induced apoptosis or cell cycle arrest. However, further studies should address this issue in more detail. On the other hand, previous data evidenced the capacity of bone marrow MSCs to support survival of unstimulated T cells [30] . Whether the same is the case for AT-MSCs whose CM did not exert an inhibitory effect on PBMCs proliferation remains to be determined.
Further on, in the present study we showed that MSCs isolated from different sources in our laboratory significantly differed in the constitutive expression of several genes related to MSCs immunomodulatory functions. All tested MSC types shared a common negative expression of HLA-G5, while the constitutive gene expression of HLA-A and HLA-DR was evidenced only for AT-MSCs.
Our results showing that all tested MSCs did not express constitutively one of the main mediators of immunosuppression, HLA-G5, were unexpected, since previously published data evidenced the expression of HLA-G5 in MSCs from different tissue sources [31] . As for the molecules related to the paracrine effects of MSCs, a marked expression of IL-6 and COX2 mRNA was demonstrated for the AT-MSCs and DP-MSCs, a low level of IDO-1 transcript only in AT-MSCs, whereas AT-MSCs, PBMSCs and UC-MSCs displayed similar low expression levels for the TGF-β mRNA.
Since the proinflammatory microenvironment has been involved in the initiation of the immunomodulatory phenotype, we also analyzed the gene expression in MSCs following stimulation with proinflammatory cytokines, such as IFN-γ and TNF-α. Our results showed that the effects of these proinflammatory cytokines differed between the MSC types. Namely, in response to IFN-γ and TNF-α, either alone or combined, an increased expression of almost all tested genes (HLA-A, HLA-DR, HLA-G, COX2, IDO-1, IL-6 and TGF-β) was determined in AT-MSCs. However, we observed that IFN-γ and TNF-α combined stimulation did not induce synergistic upregulation of the tested genes in these cells, while for the DP-MSCs the opposite effect was demonstrated as only the combined cytokine pre-treatment increased the expression of HLA-A, COX2 and IL-6. On the other hand, IFN-γ and TNF-α did not alter the expression of tested genes in PB-MSCs, while slightly stimulated the expression of HLA-G and TGF-β in UC-MSCs.
Previous studies demonstrated that IFN-γ and TNF-α not only differentially regulate the expression of various immunomodulatory factors by human MSCs, but also that these pro-inflammatory cytokines differentially affect the immune properties of different tissue-derived MSCs [32, 33] . According to our knowledge, a suppressive effect of the combination of TNF-α and IFN-γ on the expression of genes related to immunomodulatory capacity of MSCs has not been shown. Moreover, it was shown that the combination of these cytokines increased the expression of IDO-1 in bone-marrow, adipose tissue, cord blood and Wharton's jelly MSCs [34] .
Although we and other research groups showed that MSCs isolated from different tissues varied in their capacity to modulate in vitro proliferative response of allogeneic PBMCs, we cannot conclude that their different function and gene-expression profiles are entirely a consequence of their tissue origin. Indeed, in any tissue MSCs are not necessary phenotypically and functionally homogenous [35] [36] [37] , and applied isolation procedures could result in isolation of different MSCs subpopulation even from the same tissues. Also, influence of donors' age and health on properties of isolated MSCs cannot be neglected [38] , as well as impact of further cultivation and propagation [12, 13] . Besides, differences in immunomodulatory capacity of MSCs even from the same tissue origin could be a consequence of an experimental design applied in vitro, including the reciprocal influence on MSCs by the PBMC used in the assays, since their membrane or secreted molecules were also shown to affect the MSCs function [6] . Even more, it has been recently shown that MSCs can sense local microenvironment signals and in accordance with them promote optimal immune response, which can be either stimulatory or inhibitory depending on current specific needs of an organism [6] .
In general, our results confirmed that MSCs from different tissues have immunomodulatory properties, as proliferation of PBMCs in response to mitogen or alloantigens was suppressed by all tested MSCs in cell-concentration-dependent manner. In addition, data obtained using CM MSCs indicated the involvement of soluble molecules produced by MSCs in inhibition of PBMCs proliferation. However, variations in the suppression level of allogeneic PBMCs proliferation observed for different types of MSCs, as well as marked heterogeneity in the expression of genes related to immunomodulation, emphasize the importance of investigating the intrinsic molecular mechanisms underlying MSCs immunomodulatory activity in order to provide insights for defining an optimal MSC candidate for cell-base immunotherapy. 
